SOX2 and lung carcinoma: Although previous studies suggested the efficacy of SOR against lung cancer [41,43] to the best of our knowledge, there is no study evaluating the relationship between JNK and COX-2 signaling and SOX-2 in the lung premalignant microenvironment.